BENEVOLENTAI CAMBRIDGE LTD has a total of 38 patent applications. It decreased the IP activity by 70.0%. Its first patent ever was published in 2009. It filed its patents most often in United States, Australia and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and surface technology and coating are CELLTAXIS LLC, POXEL SAS and INTRA-CELLULAR THERAPIES INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 7 | |
#2 | Australia | 5 | |
#3 | EPO (European Patent Office) | 5 | |
#4 | EAPO (Eurasian Patent Organization) | 3 | |
#5 | Hong Kong | 3 | |
#6 | Israel | 3 | |
#7 | Brazil | 2 | |
#8 | Canada | 2 | |
#9 | United Kingdom | 2 | |
#10 | Hungary | 2 | |
#11 | Japan | 1 | |
#12 | Republic of Korea | 1 | |
#13 | Mexico | 1 | |
#14 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Surface technology and coating |
# | Name | Total Patents |
---|---|---|
#1 | Savory Edward | 17 |
#2 | Richardson Peter | 14 |
#3 | Higginbottom Michael | 14 |
#4 | Pritchard Martyn | 13 |
#5 | Haglund Olof | 6 |
#6 | Ashwood Michael | 6 |
#7 | Gonzalez Isabel | 6 |
#8 | Patient Lee | 6 |
#9 | Horgan Anne | 5 |
#10 | Michael Higginbottom | 3 |
Publication | Filing date | Title |
---|---|---|
GB202006437D0 | Compositions and uses thereof | |
GB202005143D0 | Compositions and uses thereof | |
EP3386494A1 | Vap-1 inhibitors for treating pain |